XII.JSE Numeral Limited
- Market cap
- ZAC 373M
- P/E
- -
- P/B
- 2,973.36x
- ROE
- 2.5%
- Dividend yield
- -
- Fundamental score
- 0.5/5
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Aug 2026.
Is XII.JSE undervalued?
Graham numberThe Graham number of Numeral Limited cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Numeral Limited fundamental analysis
3 of 22 checks passedROE 0/2
Low return on equity (2.5%), below 10%.
ROA 0/1
Return on assets (0.3%) is below the industry median (3.7%).
Profit Consistency 1/2
Profitable for 3 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 0/1
Last year's EPS growth (-99.3%) is below the industry median (24.7%).
Revenue Growth 0/2
Revenue did not grow over the past 3 years or is not reported.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 0/1
Current assets do not cover long-term liabilities.
Debt to Equity 0/2
High debt to equity (628.6%), above 100%.
Debt Trend 0/1
Debt to equity history is shorter than 5 years.
Debt Coverage 0/1
Operating cash flow does not cover 20% of total debt.
Interest Coverage 0/1
EBIT is 1.6x against interest expense, below 5x.
PE vs Market 0/1
PE is negative or not available.
PE vs Industry 0/1
PE is negative or not available.
PBV 0/1
Price to book (29.7x) is above the industry median (2.6x).
Graham Number 0/1
Graham number needs positive earnings and book value.
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Numeral Limited stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Numeral Limited
Numeral Limited, an investment holding company, engages in biotech, health and pharmaceutical, and financial businesses in Mauritius. It operates through Biotechnology and Healthcare Services, Financial Services, Investment Activities and Asset Management segments. It also provides legal support, human resources, technology support, financial services, corporate finance, and marketing, as well as business acquisition solutions. In addition, it offers stem-cell harvesting, st…
Full company profileNumeral Limited financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Aug 31, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Numeral Limited annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 1.20K | 1.82M | 4.14K | - | - | 10.78 | 0.00 | 83.0K | 1.69M | 2.20M | 2.16M |
| Gross Profit | 1.17K | 1.82M | 4.13K | -17.91 | -22.47 | 2.00 | - | 83.0K | 1.32M | 1.72M | 1.59M |
| Operating Income | 245.55 | 507K | 1.29K | -406.00 | -260.00 | -62.8K | -105.00 | 21.6K | 472K | 713K | 555K |
| EBITDA | 252.49 | 998K | -71.2K | -379.00 | -261K | -62.8K | 14.36 | 21.4K | 854K | 1.01M | 747K |
| Net Income | 18.90 | 575K | -70.7K | -70.1M | -261K | -62.8K | -91.22 | 21.6K | 1.22M | 79.9K | 18.9K |
| EPS | 0.00 | 0.06 | -0.01 | -7.79 | -0.03 | -0.01 | 0.00 | 0.00 | 0.10 | 0.00 | 0.00 |
| Balance Sheet | |||||||||||
| Total Assets | 37.2M | 38.3M | 34.9M | 303.00 | 303.00 | 303.00 | 303.00 | 32.3K | 2.79M | 5.48M | 5.97M |
| Total Liabilities | 3.22K | 3.77M | 182K | 589K | 850K | 330K | 421K | 179K | 4.78M | 5.28M | 5.71M |
| Shareholders' Equity | 33.9M | 34.5M | 34.7M | -588K | -849K | -329K | -420K | -147K | -956K | 746K | 751K |
| Cash & Short-term Investments | 382.80 | 573K | 303.00 | 303.00 | 303.00 | 303.00 | 303.00 | 303.00 | 213K | 267K | 156K |
| Total Debt | - | 3.42M | - | - | - | 250K | 339K | 104K | 3.97M | 4.15M | 4.72M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -5.45K | 188K | -444K | -34.9M | 260.82 | 62.84 | -89.5K | -16.4K | -2.08M | 121K | -76.8K |
| Capital Expenditure | 0.00 | 0.00 | 128K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 516K | 240K | 1.76M |
| Free Cash Flow | -5.45K | 188K | -572K | -34.9M | 260.82 | 62.84 | -89.5K | -16.4K | -2.59M | -118K | -1.83M |
| Ratios | |||||||||||
| ROE | 0.0% | 1.7% | -0.2% | - | - | - | - | - | - | 10.7% | 2.5% |
| ROA | 0.0% | 1.5% | -0.2% | -23,138,613.9% | -86,138.6% | -20,739.6% | -30.1% | 66.9% | 43.7% | 1.5% | 0.3% |
| Net Profit Margin | 1.6% | 31.6% | -1,709.7% | - | - | -582,940.6% | - | 26.0% | 71.9% | 3.6% | 0.9% |
| Debt to Equity | - | 0.10x | - | - | - | - | - | - | - | 5.57x | 6.29x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Numeral Limited dividends
Numeral Limited has not paid dividends in the last 9 fiscal years.
Last stock split: 1:10 on Jan 28, 2026.
Who owns Numeral Limited
Ownership data of Numeral Limited is not available yet.
Numeral Limited company profile
- Company name
- Numeral Limited
- Ticker
- XII.JSE
- Exchange
- Johannesburg Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Fiscal year end
- February
- Address
- Sayed Hossen Road, Phoenix, Mauritius
- Phone
- 230 12 012 5267
- Website
- numeral.co.za
About Numeral Limited
Numeral Limited, an investment holding company, engages in biotech, health and pharmaceutical, and financial businesses in Mauritius. It operates through Biotechnology and Healthcare Services, Financial Services, Investment Activities and Asset Management segments. It also provides legal support, human resources, technology support, financial services, corporate finance, and marketing, as well as business acquisition solutions. In addition, it offers stem-cell harvesting, storage, and related healthcare and biotechnology activities; and asset management, investment-related activities, and strategic financial initiatives. The company was formerly known as Go Life International Limited and changed its name to Numeral Limited in December 2023. Numeral Limited was incorporated in 2010 and is based in Phoenix, Mauritius.
Numeral Limited management
8- Mr. Mohamed Yusuf SooklallIndependent Non-Executive Chairman · born 1960
- Mr. Marthinus Johannes WolmaransChief Financial Officer · born 1969
- Mr. Gerhad Christiaan Jacobus NaudéGroup Advisor · born 1966
- Mr. Patrick David WysoczanskiChief Executive Officer
- Mr. David Van NiekerkExecutive Director · born 1974
- Mr. Neville David GrahamExecutive Director
- Mr. Jacobus Daniel BotmaExecutive Director
- Mr. J. J. RabieCompany Secretary